Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-10-01 17:20:52 - browse：9464

Amylyx founders — Justin Klee, left, and Joshua Cohen, both co-founders and co-CEO's of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

The Food and Drug Administration has reversed an internal decision and will now review an experimental treatment for amyotrophic lateral sclerosis — a victory for ALS patients and advocates who have been pressuring regulators to act with more urgency against the fatal, neurodegenerative disease.

Amylyx Pharmaceuticals, a Cambridge, Mass.-based drug maker, said Wednesday that it will submit an application for its ALS treatment, called AMX0035, “in the coming months.”

The filing will be based largely on a single clinical trial of AMX0035 completed one year ago that showed a significant slowing of disease progression in patients with ALS. It’s the same study that FDA officials told Amylyx last April was encouraging, but not convincing enough to review for approval on its own. The company was told by FDA staff to conduct another study, gather more positive data, and then file for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： What should King Charles tell the public about his cancer?

hotspot

WSS

Biogen Alzheimer’s drug launch off to slow start

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Robert F. Kennedy is pitching centrism on health, even on abortion

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Key House Republican on health care plans exit from Congress

Caregivers of transplant patients call for more support, training

knowledge

Wikipedia

Wikipedia

In age of alternative facts, a scholarly course on calling out crap

Fauci’s Covid grilling leads GOP to weigh foreign research rules

23andMe had bad news about my health. I wish a person had delivered it

The SUPPORT Act is critical to fighting the opioid crisis

At least 13 dead in Texas as scorching temps continue

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Apple is now the first public company to be valued at $3 trillion

Private equity deals in Medicare Advantage declines

Affirmative action in medical school literally saved lives

The Readout: Gilead, Bernie Sanders, and other pharma news

Wikipedia

What we’ve learned from the Aduhelm mess

What should King Charles tell the public about his cancer?

As JPM 2024 winds down, some health tech firms project optimism

The nurse manager staffing crisis is hurting patients

Readout LOUD podcast: live from JPM 2024

BioAge raises $170M for combination therapy with Zepbound

leisure time

focus

hotspot

hotspot